German Cancer Research Center
Clinical trials sponsored by German Cancer Research Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Experimental vaccine takes on deadly childhood brain tumors Results expected Nov 2026 (estimated)
-
New HPV vaccine enters first human tests
Vaccine Recruiting nowThis early-phase trial tests a new vaccine called PANHPVAX in 45 healthy adults aged 18-45. The vaccine targets a part of the HPV virus (L2 antigen) to potentially protect against multiple HPV types. The main goal is to check safety and how well the body's immune system responds …
Early phase 1 • Sponsor: German Cancer Research Center • Aim: Vaccine
Last updated Jun 27, 2026 08:05 UTC
-
Breast Cancer's genetic fingerprint: a new platform aims to match tumors to targeted trials
Diagnosis Recruiting nowThe COGNITION study is a molecular diagnostic platform that collects tumor and blood samples from up to 2,000 adults with early breast cancer, including those receiving chemotherapy before surgery. Researchers perform comprehensive genomic sequencing on samples taken before and a…
Sponsor: German Cancer Research Center • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
Gene-Tailored therapy could be Game-Changer for rare cancer patients
Knowledge-focused Recruiting nowThis study tests whether using a patient's unique genetic information to choose their cancer treatment leads to better results than standard care. About 946 adults with advanced rare cancers will be randomly assigned to either immediate personalized treatment or standard treatmen…
Sponsor: German Cancer Research Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Genetic roadmap for metastatic breast cancer: CATCH trial aims to match patients to targeted therapies
Knowledge-focused Recruiting nowThe CATCH trial is a large observational study for people with metastatic breast cancer. It uses advanced genetic testing on tumor biopsies to find unique biomarkers and drug targets. The goal is to create a precision medicine platform that helps guide patients toward the most pr…
Sponsor: German Cancer Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC